December 2024
Discovery opens door for new cancer drugs
Associate Professor Mark Chong is leading a project – supported by a $50,000 Tour de Cure grant – to develop a new class of drugs to inhibit certain microRNAs within the immune system as a novel immunotherapy to treat cancer.
December 2024
SVI welcomes new Foundation Chair
Jeremy was educated at Xavier College and the University of Melbourne. He enjoyed a diverse legal practice, specialising in property related matters, particularly town planning. He was a member of The Bar’s Ethics Committee for five years and Chairman of the committee that managed Foley’s List, Barristers, and a director, for nine years.
December 2024
New funding in support of type 1 diabetes research
Head of SVI's Human Immunology Lab Associate Professor Stuart Mannering has received $150k grant from JDRF for the commercialisation of his research under their new program called SPARC.
November 2024
Funds to better understand Friedreich ataxia drug
Associate Professor Shiang (Max) Lim, of SVI's O’Brien Department, has been awarded funding from the Friedreich’s Ataxia Research Alliance (FARA) to better understand the effect of omaveloxolone – a recently FDA-approved drug – on heart disease in people with Friedreich ataxia.
November 2024
Hidden 3-D atomic structure revealed – drugs for Alzheimer’s a step closer
A new study involving shooting X-rays at crystals has uncovered the precise three-dimensional structure of an enzyme associated with Alzheimer's disease, allowing researchers to now use powerful computers to discover drug-like molecules to treat the disease.
November 2024
Stars shine at soirée
The Rising Star program provides critical support to early-mid career researchers, giving them the resources they need to excel in their research and make a lasting impact, said SVI Foundation Board Chair and Rising Star founder, Karen Inge.
November 2024
Support a healthier future
SVI is home to Australia’s largest group of diabetes researchers who work passionately to better understand this debilitating condition and discover a cure. Last December, we proudly published the results of a world-first type 1 diabetes clinical trial, that offers new hope for improved treatment options. At SVI, we remain dedicated to improving the lives of those affected by type 1 diabetes.
October 2024
Innovative bioengineering to help wound healing
Dr Kate Firipis has been awarded a $75,000 Jack Brockhoff Early Career Medical Research Grant for a novel tissue engineering and regenerative medicine project. Kate works with Associate Professor Geraldine Mitchell in SVI’s Vascular Biology Lab